HIGHLIGHTS
SUMMARY
Fluconazale is usually the first line treatment, with new generation azoles such as Voriconazole used previously for resistant cases. frontiersin.org 10.3389/fped.2022.874711 Infectious uveitis in immunosuppressed patients on the eye is dose dependent and may present as anterior uveitis (with or without hypopyon), panuveitis, intermediate uveitis or retinal vasculitis. Etanercept is not efficacious in preventing the occurrence of uveitis and in controlling ocular inflammation in JIA-associated uveitis and is therefore not used in clinical practice for uveitis treatment. Similarly, a recent article reporting data from 3 registries, showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.